A PYMNTS Company

US: Antitrust suit filed against maker of Mucinex

By  |  February 8, 2015

Mutual Pharmaceutical Company and United Research Laboratories filed an antitrust suit against Reckitt Benckiser on Friday alleging unfair trade practices in the sale and distribution of Mucinex.

The plaintiffs allege Reckitt wrongfully monopolized the market for Mucinex. Reckitt allegedly deliberately blocked the formation of a competitive market for the manufacture and sale of a generic version of the drug.

The suit alleges that Reckitt has failed to provide ERG to Mutual since October 2013 when another company began selling a generic version of the drug. The plaintiffs are seeking an injunction to prevent Reckitt’s alleged monopolistic practices.

 

Full Content: The Pennsylvania Record

 

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.